IP Library Granted Patent US 7,112,435
Granted Patent B1
US 7,112,435 · App. 10/214,654 · Granted Sep 26, 2006

Uncoupling of DNA insert propagation and expression of protein for phage display

Assignee: Ambit Biosciences Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,112,435
App. No.
10/214,654
Granted
Sep 26, 2006
Kind
B1
Abstract

The present invention provides an advance in phage display technology by permitting the uncoupling of the propagation of phages containing inserted sequences encoding heterologous polypeptides from the expression of said polypeptides. The invention provides phage constructs and methods for their use to permit phage coat protein expression, and thus phage propagation, in the absence of display of heterologous polypeptides, which may be expressed as a fusion with said coat protein in a regulated manner.

Claims (13)

1. An expression system comprising

a modified T7 phage genome comprising a first nucleic acid molecule comprising a promoter and/or regulatory region operably linked, in a 5′ to 3′ orientation, to a sequence encoding a T7 phage coat protein operably linked in a 5′ to 3′ orientation to a sequence comprising a termination codon operably linked in a 5′ to 3′ orientation to a sequence encoding a heterologous polypeptide and

a suppressor construct comprising an inducible promoter and/or regulatory region operably linked to a sequence encoding a suppressor tRNA corresponding to said termination codon.

2. The system of claim 1 wherein said promoter and/or regulatory region is endogenous to a T7 phage genome.

3. The system of claim 1 wherein said promoter and/or regulatory region is an endogenous T7 promoter.

4. The system of claim 1 wherein said inducible promoter and/or regulatory region is the arabinose BAD promoter and the araC regulatory gene.

5. The system of claim 1 wherein said sequence comprising said termination codon further comprises a linker sequence encoding an enzymatic cleavage site.

6. The system of claim 1 wherein said suppressor construct further comprises an expressible sequence encoding chloramphenicol resistance.

7. The system of claim 1 wherein said termination codon is selected from UAA and UGA.

8. The system of claim 1 wherein said termination codon is UAG.

9. The system of claim 1 wherein said suppressor tRNA is tRNA Ala or tRNA Glu .

10. The system of claim 1 wherein said suppressor tRNA is tRNA Ala .

11. The system of claim 5 wherein said enzymatic cleavage site is recognized and cleaved by an enzyme selected from the group consisting of subtilisin, H64A subtilisin, Generase I, tobacco etch virus (TEV) protease, thrombin, factor Xa, and enterokinase.

Assignments (7)
CHANGE OF NAME Recorded Apr 22, 2018
From: DISCOVERX CORPORATION
To: EUROFINS DISCOVERX CORPORATION
Reel/Frame 045997/0382 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2011
From: AMBIT BIOSCIENCES CORPORATION
To: DISCOVERX CORPORATION
Reel/Frame 025732/0676 →
RELEASE OF SECURITY INTEREST Recorded Apr 15, 2010
From: FORWARD VENTURES IV, L.P.; FORWARD VENTURES IV B, L.P.; PERSEUS-SOROS BIOPHARMACEUTICAL FUND, L.P.; GIMV NV; ADVIESBEHEER GIMV LIFE SCIENCES NV; AVALON VENTURES VI, L.P.; AVALON GP FUND, L.P.; TANG CAPITAL PARTNERS, L.P.
To: AMBIT BIOSCIENCES CORPORATION
Reel/Frame 024241/0444 →
RELEASE OF SECURITY INTEREST Recorded Mar 7, 2008
From: HORIZON TECHNOLOGY FUNDING COMPANY LLC
To: AMBIT BIOSCIENCES CORPORATION
Reel/Frame 020619/0693 →
SECURITY AGREEMENT Recorded Oct 17, 2005
From: AMBIT BIOSCIENCES CORPORATION
To: HORIZON TECHNOLOGY FUNDING COMPANY LLC
Reel/Frame 017261/0630 →
SECURITY INTEREST Recorded Oct 15, 2003
From: AMBIT BIOSCIENCES CORPORATION
To: FORWARD VENTURES IV, L.P.; FORWARD VENTURES IV B, L.P.; PERSEUS-SOROS BIOPHARMACEUTICAL FUND, L.P.; GIMV NV; ADVIESBEHEER GIMV LIFE SCIENCES NV; AVALON VENTURES VI, L.P.; AVALON GP FUND, L.P.; TANG CAPITAL PARTNERS, L.P.
Reel/Frame 014056/0171 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2002
From: CICERI, PIETRO; ZARRINKAR, PATRICK PARVIS; TREIBER, DANIEL KELLY; LOCKHART, DAVID J.
To: AMBIT BIOSCIENCES CORPORATION
Reel/Frame 013232/0095 →